Literature DB >> 28126181

Diagnosis, classification, and treatment of femoropopliteal artery in-stent restenosis.

Karen J Ho1, Christopher D Owens2.   

Abstract

In-stent restenosis is a pervasive challenge to the durability of stenting for the treatment of lower extremity ischemia. There is considerable controversy about the criteria for diagnosis, indications for treatment, and preferred algorithm for addressing in-stent restenosis. This evidence summary seeks to review existing information on strategies for the treatment of this difficult problem.
Copyright © 2016 Society for Vascular Surgery. All rights reserved.

Entities:  

Mesh：

Year:  2017        PMID： 28126181     DOI： 10.1016/j.jvs.2016.09.031

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN： 0741-5214            Impact factor:   4.268


  7 in total

1.  Intravascular ultrasound guided directional atherectomy versus directional atherectomy guided by angiography for the treatment of femoropopliteal in-stent restenosis.

Authors:  Prakash Krishnan; Arthur Tarricone; Purushothaman K-Raman; Farhan Majeed; Vishal Kapur; Karthik Gujja; Jose Wiley; Miguel Vasquez; Rheoneil A Lascano; Katherine G Quiles; Tashanne Distin; Ran Fontenelle; Farah Atallah-Lajam; Annapoorna Kini; Samin Sharma
Journal:  Ther Adv Cardiovasc Dis       Date:  2018-01

2.  FAK Activation Promotes SMC Dedifferentiation via Increased DNA Methylation in Contractile Genes.

Authors:  Kyuho Jeong; James M Murphy; Jung-Hyun Kim; Pamela Moore Campbell; Hyeonsoo Park; Yelitza A R Rodriguez; Chung-Sik Choi; Jun-Sub Kim; Sangwon Park; Hyun Joon Kim; Jonathan G Scammell; David S Weber; Richard E Honkanen; David D Schlaepfer; Eun-Young Erin Ahn; Ssang-Taek Steve Lim
Journal:  Circ Res       Date:  2021-10-27       Impact factor: 17.367

3.  [Application of Rotarex mechanical thrombectomy system in treating in-stent restenosis of lower extremity arteriosclerosis obliterans].

Authors:  J M Zhuang; T R Li; X Li; J Y Luan; C M Wang; Q C Feng; J T Han
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2021-08-18

4.  The Application of Targeted Nanodrugs with Dual Responsiveness of PH and Ros in Preventing and Treating Vascular Restenosis.

Authors:  Jin Zhang
Journal:  J Healthc Eng       Date:  2021-11-26       Impact factor: 2.682

5.  Endovascular Treatment and Outcomes for Femoropopliteal In-Stent Restenosis: Insights from the XLPAD Registry.

Authors:  Michael H Vu; Glaiza-Mae Sande-Docor; Yulun Liu; Shirling Tsai; Mitul Patel; Chris Metzger; Mehdi H Shishehbor; Emmanouil S Brilakis; Nicolas W Shammas; Peter Monteleone; Subhash Banerjee
Journal:  J Interv Cardiol       Date:  2022-07-15       Impact factor: 1.776

6.  Retained Functionality of Atherosclerotic Human Arteries Following Photoactivated Linking of the Extracellular Matrix by Natural Vascular Scaffolding Treatment.

Authors:  Ejaz Ansari; Blake Anderson; Katalin Kauser
Journal:  J Cardiovasc Transl Res       Date:  2020-08-03       Impact factor: 4.132

Review 7.  Drug-coated balloon in superficial femoral artery in-stent restenosis.

Authors:  Donato Gerardi; Arturo Alfani; Tullio Tesorio; Angelo Cioppa; Giovanni Esposito; Eugenio Stabile
Journal:  Postepy Kardiol Interwencyjnej       Date:  2018-03-22       Impact factor: 1.426
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.